SCHEMBL3338643

SCHEMBL3338643

[CH2]C(=C)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565974 0.81 CES2 (0.64)
SCHEMBL13656482 0.81 CES2 (0.56)
Ethylene SCHEMBL28075502 0.79 CES2 (0.61)
SCHEMBL31560056 0.79 CES2 (0.54)
SCHEMBL14082103 0.79
SCHEMBL4196929 0.79 CES2 (0.61)
SCHEMBL5873384 0.79 CES2 (0.61)
SCHEMBL24577735 0.78 DAO (0.64)
SCHEMBL25334439 0.78 DAO (0.64)
SCHEMBL9511706 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100099880-A1 Alternate Process for Remifentanil Preparation MALLINCKRODT INC. 2010-04-22 US claimed
EP-2125730-A2 NEW PROCESS FOR REMIFENTANIL SYNTHESIS Mallinckrodt Inc. (US) 2009-12-02 EP claimed
EP-2081899-A2 ALTERNATE PROCESS FOR REMIFENTANIL PREPARATION Mallinckrodt Inc. (US) 2009-07-29 EP claimed
WO-2008066708-A2 NEW PROCESS FOR REMIFENTANIL SYNTHESIS MALLINCKRODT INC. (US) 2008-06-05 WO claimed
WO-2008045192-A2 ALTERNATE PROCESS FOR REMIFENTANIL PREPARATION MALLINCKRODT INC. (US) 2008-04-17 WO claimed
EP-0647225-A1 3-ARYLURACIL DERIVATIVES AND THEIR USE AS HERBICIDES Novartis AG (CH) 1995-04-12 EP claimed
US-11993626-B2 Functionalized N-acetylgalactosamine analogs HONGENE BIOTECH CORPORATION (US) 2024-05-28 US disclosed
US-5665746-A BACTERICIDE HOFFMANN-LA ROCHE INC. (US) 1997-09-09 US disclosed
EP-0522956-B1 Preparation of 2-(2-thienyl) ethylamine and synthesis of thieno [3,2-C] pyridine derivatives therefrom SANOFI SA (FR) 1997-02-05 EP disclosed
US-5594135-A BACTERICIDES HOFFMANN-LA ROCHE INC. (US) 1997-01-14 US disclosed
US-5589473-A BACTERICIDES HOFFMANN-LA ROCHE INC. (US) 1996-12-31 US disclosed
EP-0535192-B1 NOVEL DNA GYRASE INHIBITORS, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME HOFFMANN LA ROCHE (CH) 1996-06-19 EP disclosed
US-5516910-A N--2--chlorobenzyl--2--oxo and n--2--chlorobenzyl--2,2--dioxo--1,2,3--oxathiazolidine derivatives, their preparation and synthesis of thieno[3,2--c]pyridine derivatives therefrom SYNTEX (U.S.A.) INC. (US) 1996-05-14 US disclosed
EP-0535192-A1 NOVEL DNA GYRASE INHIBITORS, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME. HOFFMANN LA ROCHE (CH) 1993-04-07 EP disclosed
US-5191090-A Preparation of 2-(2'-thienyl)ethylamine derivatives and synthesis of thieno[3,2-c]pyridine derivatives therefrom SYNTEX (U.S.A.) INC. (US) 1993-03-02 US disclosed
EP-0522956-A2 Preparation of 2-(2-thienyl) ethylamine and synthesis of thieno [3,2-C] pyridine derivatives therefrom SANOFI (FR) 1993-01-13 EP disclosed
WO-1992018490-A1 NOVEL DNA GYRASE INHIBITORS, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME F. HOFFMANN-LA ROCHE AG (CH) 1992-10-29 WO disclosed
EP-0497695-A1 N-2-chlorobenzyl-2-oxo and N-2-chlorobenzyl-2,2-dioxo-1,2,3-oxathiazolidine derivatives, their preparation and synthesis of thieno[3,2-c]pyridine derivatives therefrom SANOFI (FR) 1992-08-05 EP disclosed
US-5068360-A Preparation of 2-(2'-thienyl)ethylamine derivatives and synthesis of thieno(3,2-C)pyridine derivatives therefrom SYNTEX (U.S.A.) INC. (US) 1991-11-26 US disclosed
EP-0439404-A2 Preparation of 2-(2'-thienyl) alkylamines and derivatives thereof and synthesis of 4,5,6,7- thieno [3,2-c] pyridine derivatives therefrom SANOFI (FR) 1991-07-31 EP disclosed